Philips’ contract of supplying ventilators to HHS partially terminated
Category: #headlines  | By Nikita Chaurasia  | Date: 2020-09-02 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Philips’ contract of supplying ventilators to HHS partially terminated

Royal Philips, global leader in health technology recently declared to have halted the supply of ventilators to the U.S. Department of Health and Human Services (HHS), after receiving a notice regarding partial termination of contract which was signed by the two parties earlier in April.

The contract stated that Philips will deliver over 43,000 bundled EV300 ventilators configurations to HHS by December 2020. As per trusted sources, the company has provided over 12,300 ventilators to the Strategic National Stockpile as of August. However, the remaining 30,700 Philips ventilators will not be supplied by the health tech giant following the recent turn of events.

Frans van Houten, CEO at Royal Philips was reported stating that the company increased the production of ventilators by four times under pressure and urgency amidst COVID-19 pandemic, with the help of significant investments.

Frans van Houten added that the company had hired new colleagues for the factories in the U.S. and also had called up their supply-chain partners to help in response to the global crisis. Philips will focus on adjusting its plans such as ensuring business continuity, safeguarding employee’s health and safety and satisfying customer need, following the partial termination of the deal with HHS, the CEO claimed.  

Frans confirmed that the company is committed in helping the government and its agencies in supporting healthcare providers with monitoring, treatment, diagnosis and management of COVID-19 patients.

If sources are to be believed, Philips has a broad portfolio of products, services and solutions in order to support the provision of state-of-the-art care to patients suffering from coronavirus. These solutions include intelligent, connected and secure approaches to treatment and diagnosis.  It appears that Philips' AI-enabled data analytics and telehealth solutions can support workflows as well as facilitate remote collaboration.

In other news, the United States backed out from the WHO-led global effort in manufacturing and distributing COVID-19 vaccines, after President Donald Trump reportedly criticized the health agency in covering up the spread of the disease.

Source credits-

https://www.benzinga.com/pressreleases/20/08/tr17302581/philips-ev300-ventilator-supply-contract-with-u-s-department-of-health-and-human-services-to-end-

https://www.newindianexpress.com/world/2020/sep/02/us-backs-out-from-global-effort-to-develop-distribute-covid-19-vaccine-2191482.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Fintech firm PayPal to shed around 2000 staff as global economy plummets

Fintech firm PayPal to shed around 2000 staff as global economy plummets

By Nikita Chaurasia

PayPal, the U.S.-based fintech giant, has reportedly announced that it will cut nearly 2000 jobs, approximately 7% of its workforce, as it turns the latest prominent tech company to shed staff in a bid to cut costs. The online payments provider cl...

EasyJet sees a rise in bookings as customers plan their next vacations

EasyJet sees a rise in bookings as customers plan their next vacations

By Nikita Chaurasia

British multinational low-cost airline group, EasyJet, has reported a record surge in bookings for the month of January as people prioritized their travel plans for the coming year. The news comes as airlines world over start to show signs that they&...

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

By Nikita Chaurasia

Dr. Reddy's Laboratories Ltd. and Cipla Ltd. surpassed Aurobindo Pharma to rank as the 2nd and 3rd largest drug manufacturers in India by sales in the three months that ended on September 30. This was the first change in the pecking order of the ...